This guide specifically addresses issues such as stigma and work discrimination, and also provides practical recommendations on how to establish an effective monitoring system.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2013
This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
Favorite
International Agencies
Policy Makers
2013
This webinar provides information that providers need to know when working with patients with compromised liver function due to taking TB medication.
Favorite
2013
This website provides answers to common questions regarding a bronchoscopy.
Favorite
Parents/Families
2013
This 15-minute video provides basic TB information and promotes a collaborative approach to addressing TB in the African American community. Suggested venues for showing the video include waiting rooms in health department clinics, substance abuse treatment centers, correctional facilities, barbershops, and other community-based settings where educational content is appropriate...
Favorite
Black or African American persons
Community Based Organizations
Community Leaders
Health Educators/Communicators
2013
This fact sheet provides information regarding TB/HIV coinfection worldwide. It also presents key activities being conducted by the WHO in response to TB/HIV coinfection.
Favorite
Health Educators/Communicators
2013
The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. For each of the three CDC-recommended LTBI regimens, there is a fact sheet in the series that can be personalized for individual patients. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.
Favorite
2013
This document is designed to serve as a handbook, or primer, for NGOs and CSOs that are considering joining the fight against TB. It provides information on TB and how it is prevented, diagnosed, and treated, how TB programs work on the ground, how communities and CSOs can get involved, and special populations that need extra attention...
Favorite
Community Leaders
International Agencies
Social Service Providers
2013
The main purpose of this guide is to describe and explain how to design, implement and analyse an inventory study to measure TB under-reporting. The guide also explains how to apply capture-recapture methods to estimate TB incidence, emphasizing the conditions that must be fulfilled for these methods to be used...
Favorite
International Agencies
Managers and Supervisors
2013
In this video, Dr. Caralee Caplan-Shaw and her patients clarify the risks of untreated latent TB infection and motivate your patients to complete treatment.
Favorite
Persons With LTBI
2013
World TB Day poster available in 5 languages: Creole, English, French, Portuguese, and Spanish
Favorite
2013
The multimedia videos are targeted to community health providers, including those working at Federally Qualified Health Centers. The series contains three videos, each of which is 6 -15 minutes long, and seamlessly incorporate images, voice and text. The videos cover screening, diagnosis and treatment of LTBI...
Favorite
2013
The US Agency for International Development (USAID) has reported to Congress on its international foreign assistance efforts to control tuberculosis (TB). Titled Leading and Leveraging, the report documents work completed the previous fiscal year.
Favorite
International Agencies
Policy Makers
2013
This application, created by the WMA and the New Jersey Medical School Global Tuberculosis Institute, gives physicians the flexibility to access the course material at any time, even when they are discussing treatment options with their patients. The application was developed in collaboration with the World Health Organization with financial support from the Eli Lilly MDR-TB partnership...
Favorite
2013
This document revises previous WHO standard case definitions for TB and drug-resistant TB, the categories used to assign outcomes, and the standard reporting framework for TB.
Favorite
International Agencies
2013
This tool is designed to support the effective monitoring and evaluation (M&E) of tuberculosis (TB) control programs in refugee camps and other settings located in resource-poor areas.
Favorite
International Agencies
2013
This guide was developed to help advocacy, communication, and social mobilization (ACSM) programs at national and subnational levels strengthen routine monitoring and evaluation of tuberculosis ACSM activities.
Favorite
Health Educators/Communicators
International Agencies
Managers and Supervisors
2013
This fact sheet describes the impact of HIV-TB co-infection. It also presents work currently being done to find and treat HIV-TB.
Favorite
International Agencies
Policy Makers
2013
Based on The Union's 93-years of working in the field, the new guide tackles the challenges of fulfilling each patient's potential for cure from both the clinician's and the programme manager's perspective.
Favorite
International Agencies
Managers and Supervisors
2013
This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).
Favorite
2013
